SANUWAVE HEALTH INC - SNWV STOCK NEWS

SANUWAVE Health (SNWV) will host a conference call on October 22, 2021, at 9:00 am ET to review recent business developments, SEC filing updates, and strategic initiatives. Investors can access the call via toll-free numbers: 1-877-407-0784 (U.S.) and 1-201-689-8560 (international). A replay will be available until November 5, 2021, with access numbers: 1-844-512-2921 (U.S.) and 1-412-317-6671 (international), using the passcode 13724589. SANUWAVE focuses on non-invasive medical systems for skin and tissue regeneration, employing patented energy transfer technologies in various health conditions.

SANUWAVE Health, Inc. (PINK: SNWV) announced its shares will cease trading on the OTC Market Pink due to untimely financial report filings with the SEC, moving to the expert market instead. Despite this, the company reported strong operational performance with record unit shipments in August and a robust pipeline. Management expects to achieve break-even sales and outlines plans for cost savings through manufacturing relocations. Updates on financial reports and a conference call to discuss results are anticipated.

SANUWAVE Health (OTCQB: SNWV) has announced a collaboration with NASA to tackle bacterial biofilms in the Water Recovery System (WRS) essential for long-duration space missions. Utilizing their proprietary shockwave technology, SANUWAVE aims to prevent biofilm formation that poses risks to water systems used in human habitats on the Moon and Mars. This partnership is significant for ensuring clean water for future lunar and Martian missions, and SANUWAVE's innovative solutions may extend to various commercial applications in water cleaning and disinfection.

SANUWAVE Health (OTCQB:SNWV) has announced updated dial-in instructions for its conference call on July 15, 2021, at 4:30 PM ET. The call will cover recent business activities, SEC filing updates, and strategic initiatives. Participants can join by calling Toll-Free: 844-407-9500 or International: 862-298-0850. A replay will be available through July 22, 2021, using Toll-Free: 877-481-4010 and International: 919-882-2331 with the passcode 42095. SANUWAVE focuses on advanced wound care and regenerative medicine.

SANUWAVE Health (OTCQB:SNWV) will host a conference call on July 15, 2021, at 4:30pm ET, to discuss recent business activities, SEC filings, and strategic initiatives. All interested parties can access the call by dialing 678-578-0113 in the U.S. SANUWAVE focuses on developing next-generation wound care products utilizing patented energy transfer technologies aimed at enhancing wound healing and tissue regeneration. Further information about SANUWAVE can be found at www.SANUWAVE.com.

SANUWAVE Health (OTCQB:SNWV) announced on July 2, 2021, that its shares will transition to pink sheets due to late financial filings with the SEC. The CEO, Kevin Richardson, attributed the delays to accounting system issues, asserting they are being resolved and that current filings are forthcoming. The company remains optimistic about its operations, citing a distribution agreement in Latin America and strong clinical study results. Their UltraMIST systems are seeing record sales, and the recent relaunch of the ENERGY FIRST platform is gaining traction, suggesting potential growth ahead.

SANUWAVE Health, Inc. (OTCQB:SNWV) recently reported promising results from a clinical case series on its dermaPACE System, an FDA-cleared treatment for diabetic foot ulcers. The study, published in the American Journal of Nursing Science, showed a 25% increase in tissue oxygen saturation and a 46.7% full wound closure rate among patients over four weeks. This signifies the system's effectiveness in enhancing wound healing and could transform management strategies for chronic wounds in diabetic patients, impacting around 30.3 million Americans.

SANUWAVE Health, Inc. (OTCQB:SNWV) announces its participation in the LD Micro Invitational XI conference, scheduled for June 8-10, 2021. CEO Kevin Richardson will present on June 10, 2021, at 4:30 p.m. EDT. The presentation will cover SANUWAVE's innovative wound care solutions that leverage patented biological response-activating technologies. Interested parties can access a live audio webcast at this link. The company focuses on non-invasive medical systems for healing and regeneration in various medical fields.

SANUWAVE Health, Inc. (OTCQB:SNWV) has announced a distribution agreement with Grupo Suprimed to market and sell its dermaPACE System in Brazil's private healthcare sector. This agreement aims to strengthen SANUWAVE's presence in Brazil, the largest healthcare market in Latin America, which has a vast network of hospitals and healthcare professionals. SANUWAVE’s CEO highlighted the potential for improving healthcare quality and lowering costs through this partnership, while Grupo Suprimed is recognized as a significant distributor of medical products in the region.